London Daily
Focus on the big picture.

LONDON DAILY ARCHIVE

Eli Lilly Chief Labels UK Worst in Europe for Drug Prices

Pharmaceutical leader points to major challenges in British healthcare market

24 September 2025 · 23:32 UTC

The chief executive of Eli Lilly has described the United Kingdom as the worst country in Europe for pharmaceutical pricing, warning that restrictive costs are undermining incentives for investment and innovation.

The remarks reflect broader tensions between drug companies and the British government over access, affordability, and long-term healthcare sustainability.